These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4287550)
1. Treatment of severe myasthenia gravis with large doses of ACTH. von Reis G; Liljestrand A; Matell G Ann N Y Acad Sci; 1966 Jan; 135(1):409-16. PubMed ID: 4287550 [No Abstract] [Full Text] [Related]
2. [Treatment of myasthenia with adrencorticotrophins (ACTH and Synacthen). Apropos of 100 treatments in 25 patients]. Goulon M; Nouailhat F; Barois A; Grosbuis S; Joron MH Rev Neurol (Paris); 1972 Oct; 127(4):457-70. PubMed ID: 4355521 [No Abstract] [Full Text] [Related]
3. Results with ACTH and spironolactone in severe cases of myasthenia gravis. von Reis G; Liljestrand A; Matell G Acta Neurol Scand Suppl; 1965; 13 Pt 2():463-71. PubMed ID: 4284453 [No Abstract] [Full Text] [Related]
7. [Treatment of myasthenia with the aldosterone antagonist spironolactone]. Lincke HO Munch Med Wochenschr; 1966 Feb; 108(5):270-4. PubMed ID: 6013740 [No Abstract] [Full Text] [Related]
8. The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis. Oosterhuis HJ; van der Slooten EP J Neurol Sci; 1973 Aug; 19(4):453-60. PubMed ID: 4579659 [No Abstract] [Full Text] [Related]
9. Corticotropin therapy in myasthenia gravis: indications and limitations. Namba T; Shapiro MS; Brunner NG; Grob D Neurology; 1970 Apr; 20(4):385. PubMed ID: 4327339 [No Abstract] [Full Text] [Related]
10. Benefit from adrenocorticotrophin in myasthenia gravis. Liversedge LA; Yuill GM; Wilkinson IM; Hughes JA J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):412-5. PubMed ID: 4365243 [TBL] [Abstract][Full Text] [Related]
11. Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. Grob D; Namba T JAMA; 1966 Nov; 198(7):703-7. PubMed ID: 4288482 [No Abstract] [Full Text] [Related]
12. Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment. Cape CA; Utterback RA J Neurol Neurosurg Psychiatry; 1969 Aug; 32(4):290-6. PubMed ID: 4309018 [No Abstract] [Full Text] [Related]
13. [Treatment of myasthenia with corticotropic hormones]. Goulon M; Barois A; Gajdos P; Grosbuis S; Joron MH; Bennaiche M Sem Hop; 1972 Dec; 48(51):3371-5. PubMed ID: 4347494 [No Abstract] [Full Text] [Related]
14. The use of ACTH and corticosteroids in myasthenia gravis. Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763 [No Abstract] [Full Text] [Related]
15. [Treatment of myasthenia gravis]. Matell G; von Reis G Lakartidningen; 1973 Oct; 70(43):3821-5. PubMed ID: 4362569 [No Abstract] [Full Text] [Related]
20. EMG findings in mild cases of myasthenia gravis during and after a short course of moderate doses of ACTH. Pinelli P Electroencephalogr Clin Neurophysiol; 1968 Jul; 25(1):82. PubMed ID: 4174788 [No Abstract] [Full Text] [Related] [Next] [New Search]